This content is machine translated Lipoprotein(a) Current and future treatment options Twenty percent of the population have elevated Lp(a) concentrations, which are associated with an increased risk of cardiovascular disease. There is currently no FDA or EMA approved pharmacologic therapy to… CME-Test
